Exact Sciences (EXAS) Thoughts After Post-Earnings NDR - Stifel

February 14, 2020 7:54 AM EST Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $110.00 price target on Exact Sciences (NASDAQ: EXAS) after hosting investor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login